Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial

202012 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov, NCT03345810; initially registered on 17 November 2017. Eudra-CT, 2016-003963-20; initially registered on 3 January 2017.

Good health and well-being

Published in: Trials

Volume 21, Issue 1, pp. 352-352

Field-Weighted Citation Impact: 0.67